Beverly Barr has over 25 years’ international healthcare experience spanning pharmaceuticals, biotechnology, medical devices, diagnostics, and rare diseases. During her career she has held senior positions in leading healthcare and market access consultancies as well as communication companies.
Beverly has considerable expertise in HTA EMA/HTA scenario planning, parallel consultation, early evidence generation, payer and patient research, value communications, and global-to-local implementation. She is the author of peer reviewed publications and industry articles as well as a contributor to leading reports on market access and patient engagement. Beverly is also the immediate past Vice-Chair and Head of the Market Access Group of the Pharmaceutical Marketing Society, UK.
Beverly is the Senior Advisor at a specialist pricing reimbursement and market access consultancy (PRMA Consulting) where she provides strategic advice and solutions in response to the rapidly changing market access, HTA, and policy requirements.